Related Experiment Video
Updated: Jul 19, 2026

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
Published on: May 23, 2025
Outcomes after major hepatectomy in elderly patients
Krishna V Menon1, Ahmed Al-Mukhtar, Amer Aldouri
1HPB and Transplant Unit, St James's University Hospital, Leeds, United Kingdom.
Major liver resections are safe for patients aged 70 and older, showing similar outcomes and survival rates compared to younger patients. Key survival predictors include American Society of Anesthesiologists grade and transfusion volume.
Area of Science:
- Hepatobiliary Surgery
- Surgical Outcomes Research
- Geriatric Surgery
Background:
- Assessing the safety and efficacy of major liver resections in elderly patients (70+ years).
- Comparing outcomes of major liver resections in elderly versus younger patient cohorts.
Purpose of the Study:
- To evaluate early and long-term outcomes of major liver resections in patients aged 70 years and older.
- To compare these outcomes with those of patients younger than 70 years.
Main Methods:
- Retrospective analysis of 517 patients undergoing major liver resection (≥3 segments) between 1993 and 2004.
- Patients divided into two groups: 70 years and older (elderly, n=127) and younger than 70 years (young, n=390).
- Analysis of operative mortality, postoperative morbidity, overall survival, and disease-free survival.
Main Results:
- No significant differences in operative mortality (7.9% vs 5.4%) or postoperative morbidity between elderly and young groups.
- Overall survival (59% vs 57%) and disease-free survival (60% vs 55%) were comparable.
- For colorectal liver metastases subgroup, survival rates were also similar.
- Multivariable analysis identified American Society of Anesthesiologists grade 3 and >3 intraoperative transfusions as predictors for overall survival.
- More than three tumors and redo resection predicted disease-free survival.
Conclusions:
- Major liver resections are safe and effective in patients aged 70 years and older.
- Outcomes and survival rates are comparable to younger patients undergoing similar procedures.
- Predictors of survival include patient comorbidities and intraoperative factors like transfusion requirements.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
